Riskpilot← Back to searchSign inGet full accessLICA PHARMACEUTICALS A/S
A/SActiveCVR 25332520Tuborg Havnepark 2, 1. tvResearch and experimental development on natural sciences and engineering · NACE 7210Est. 2000— employees
Revenue 2024
DKK 210K
-10% vs 2023
EBITDA margin
100.0%
-10% vs 2023
Equity ratio
98.4%
Financial strength
Net profit 2024
DKK 1,4M
-19% vs 2023
| Revenue | DKK 210K | -10% |
| EBITDA | DKK 210K | -10% |
| Net profit | DKK 1,4M | -19% |
| Total assets | DKK 24,2M | +8% |
| Equity | DKK 23,8M | +6% |
| Employees | — | — |
Legal name
LICA PHARMACEUTICALS A/S
CVR number
25332520
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12. april 2000
Share capital
DKK 500.550
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af fire bestyrelsesmedlemmer i forening
Company purpose
Selskabets formål er at drive virksomhed med forskning indenfor medicinalbranchen og hermed beslægtet virksomhed med henblik på kommerciel udnyttelse og salg af forskningsresultaterne.
Address
Tuborg Havnepark 2, 1. tv
Phone
+4540107500
Email
ak@kharazmi.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 468 | 341 | 269 | 312 | 738 | 409 | 973 | 280 | 326 | 371 | 313 | 234 | 210 |
| Staff expenses | -60 | -42 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 236 | 299 | 269 | 312 | 738 | 409 | 973 | 280 | 326 | 371 | 313 | 234 | 210 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 236 | 299 | 269 | 312 | 738 | 409 | 973 | 280 | 326 | 371 | 313 | 234 | 210 |
| Net financials | 718 | 483 | 3.601 | -2.567 | -410 | 404 | 4.599 | 2.102 | 762 | 2.920 | -2.262 | 1.990 | 1.605 |
| Profit before tax | 953 | 783 | 3.870 | -2.255 | 328 | 812 | 5.572 | 2.382 | 1.088 | 3.290 | -1.949 | 2.224 | 1.816 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -401 | 244 | 726 | -425 | 493 | 409 |
| Net profit | 953 | 783 | 3.870 | -2.255 | 328 | 812 | 5.572 | 2.782 | 844 | 2.564 | -1.525 | 1.731 | 1.407 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9.276 | 10.057 | 13.942 | 11.744 | 12.096 | 12.898 | 18.457 | 18.892 | 19.737 | 22.300 | 20.730 | 22.448 | 24.158 |
| Equity | 9.258 | 10.041 | 13.911 | 11.655 | 11.983 | 12.795 | 18.368 | 18.750 | 19.594 | 22.157 | 20.633 | 22.364 | 23.771 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 18 | 16 | 31 | 89 | 113 | 102 | 89 | 142 | 144 | 142 | 97 | 84 | 387 |
| Total debt | 18 | 16 | 31 | 89 | 113 | 102 | 89 | 142 | 144 | 142 | 97 | 84 | 387 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
98.4%
This company
38.2%
Market median
+158% vs market
20122024
Return on equity
5.9%
This company
18.4%
Market median
-68% vs market
20122024
Net profit margin
669.0%
This company
8.1%
Market median
+8159% vs market
20122024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20122024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PT Founder | Founder | 2000 | — | — |
AK Chief Executive Officer | Chief Executive Officer | 2000 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2005 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2001 | — | — | |
| Deputy Chairman | 2000 | — | — | |
| Board of Directors | 2000 | — | — | |
| Deputy Chairman | 2005 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 2005 | — | — | |
| Chairman | 2000 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BIOSEARCH ApS | Company | 100.0% | 100.0% | 2005 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIOSEARCH ApS
LICA PHARMACEUTICALS A/S Board members of LICA PHARMACEUTICALS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Thor Lassen | Founder | 0 companies |
| Arsalan Kharazmi | Chief Executive Officer | 0 companies |
| Karin Birgitte Sonne Kharazmi | Chairman | 0 companies |
| Gunnar Magnus Severus Modée Persson | Board of Directors | 0 companies |
| Per Anders Göte Samuelsson | Board of Directors | 0 companies |
| Michele Garufi | Board of Directors | 0 companies |
| Eva Steiness | Deputy Chairman | 0 companies |
| Björn Ingemar Odlander | Board of Directors | 0 companies |
| Leila Eileen Gedsø-Kharazmi | Deputy Chairman | 0 companies |
| Søren Brøgger Christensen | Board of Directors | 0 companies |
| Mark Sonne Kharazmi | Board of Directors | 0 companies |
| Michael Betto Vibe Fiorini | Chairman | 0 companies |